Generating the First Clinical-Grade hESC Lines – an Interview with Dr. Zoe Hewitt
Earlier this year, the UK Stem Cell Bank validated the first European Union of Tissue and Cell Directives (EUTCD)-compliant human embryonic stem cell (hESC) lines: the MasterShef hESC lines 2, 7, and 10. Derived at the University of Sheffield Center for Stem Cell Biology, these clinical-grade hESC lines are a major breakthrough for researchers requiring […]
Observations from the Field: Evaluation of Human Platelet Lysate and Serum-Free Media as Alternatives to FBS for Human MSC Culture
Comparison study showing the growth and expansion of adipose-derived hMSCs using a variety of media, supplements, and attachment substrates As more human mesenchymal stem/stromal cell (hMSC)-based therapies move closer to the clinic, the culture conditions used to propagate these cells in vitro are increasingly coming into the spotlight. We see this reflected every day by […]
BI-USA’s Summer of Support for Stem Cell Research Training Programs
In an effort to support these various stem cell research training programs, Biological Industries USA (BI-USA) has partnered with Pathways to Stem Cell Science to provide scholarships to aspiring high school scientists to enable them to participate in these unique research opportunities.
Interview with Dr. Alessandro Rosa
In this interview, Dr. Alessandro Rosa offers insight and tips for working with high cell quality standards for expansion and differentiation of iPSC to fates such as motor neurons and skeletal muscle.
Biological Industries USA to Support Training Programs for Young Scientists through Partnership with Non-Profit Institute Pathways to Stem Cell Science
Biological Industries USA (BI-USA) is proud to announce an exciting partnership designed to support real-world laboratory skills training in regenerative medicine for early career scientists.
An Introduction to the Evolution of Human Pluripotent Stem Cell Culture Systems
The Evolution of Human Pluripotent Stem Cell Culture Systems (Originally posted on RegMedNet February 2017) Human pluripotent stem (hPS) cells can proliferate for years or more as self-replicating, unspecialized cells, yielding an exponentially expanding number of stem cells in culture – each with the ability to differentiate into any cell or tissue in the body. […]
Spotlight on iPSC production
Biological Industries sponsors RegMedNet 2-month focus on the production of iPSCs March 31, 2017 (RegMedNet.com) Induced pluripotent stem cells (iPSCs) are arguably one of the hottest topics within regenerative medicine. The first generation of iPSCs 10 years ago marked a huge milestone in the field, leading to great progress from disease modeling to development of […]
Biological Industries USA Signs Agreement With Mill Creek Life Sciences To Add PLTMax Human Platelet Lysate To Its Growing Stem Cell Portfolio
PLTMax® is a superior GMP alternative to FBS supplementation for adult stem cell media Combination of PLTMax® and NutriStem® MSC Medium creates a clinically relevant culture system, offering superior growth and cellular properties for the culture of human mesenchymal stem cell (MSC) culture. CROMWELL, Conn.–(BUSINESS WIRE)–Biological Industries USA (BI-USA), a division of Biological Industries […]
Choosing the Right hPSC Medium – Points to Consider
Today, when it comes to choosing which human pluripotent stem cell (hPSC) medium to use for your stem cell cultures, scientists and clinicians have many choices. You may be asking yourself “How do I know which media I should be using?” or “How do I choose the right media for me?” In this blog post, I […]
cGMP: What every Life Science Researcher should know about current Good Manufacturing Practice
An interview with Ravid Grimberg, Biological Industries VP of Quality Assurance & Regulatory Affairs, Israel Can you tell us about yourself? After finishing my bachelor’s degree in Biology and my master’s degree in Quality Assurance and Reliability from The Technion-Israel Institute of Technology, I gained experience by working in different positions in QA and RA […]
2016 BI-USA Year in Review
As 2016 comes to a close, we want to take this opportunity to extend our gratitude for our great new relationships. Whether you are a customer or a friend of BI and BI-USA, we appreciate the trust that you have placed in us and the opportunity to work with you throughout all of 2016. We […]
Biological Industries announces FDA Drug Master File Acceptance for NutriStem® hPSC XF Medium
KIBBUTZ BEIT HAEMEK, Israel and CROMWELL, CT, USA – November 30, 2016 – Biological Industries (“BI”) announced today that the United States Food and Drug Administration (FDA) has accepted the submission for its Drug Master File (DMF) for the company’s NutriStem® hPSC XF Medium, a chemically defined, xeno-free, serum-free media, which is designed to support […]